The science —
and how to work with us.
Person Health is building differentiated diagnostics and a health intelligence platform, launching for Research Use Only as evidence and future clinical pathways advance. We'd welcome your scrutiny — and your partnership.
We read the whole pattern —
not a single marker.
Most tests look for one narrow signal against one threshold. Person Health reads a broader molecular pattern across blood and breath, because the pattern can shift before a single marker does — then applies governed data integration and analytical models to interpret it.
Rigor first, claims second.
We're deliberately conservative about what we say, and deliberate about how we prove it. Detailed performance data is shared through appropriate scientific and diligence channels — not marketed on a website.
Blinded validation
Our analytical work is structured with blinding designed to reduce bias and reflect real-world conditions.
Trained & locked models
Where models are used, they are trained and then locked — so evaluation happens on a fixed, reproducible system.
Research-first rollout
We begin through research-use and clinician-led channels while evidence and future clinical laboratory pathways advance.
Four ways to engage.
We're actively building relationships with clinicians and researchers who want to help shape — and pressure-test — what comes next.
Co-develop the evidence
Design and run studies, and evaluate the platform on cohorts relevant to your work.
Bring it into care
Integrate the platform into clinician-led care and real workflows as pathways mature.
Strengthen the proof
Contribute to analytical validation and longitudinal evidence development.
Guide the direction
Provide clinical and scientific counsel as the platform expands into new areas.
Research Use Only — by design
- Not for use in diagnostic procedures
- Clinician-led, research-use channels
- Evidence and diligence shared appropriately
- Confident, not apologetic
Toward future clinical pathways
- Building the evidence base deliberately
- Advancing toward clinical laboratory pathways
- Expanding across diseases and modalities
- On a timeline we won't overpromise
Bring us your hardest questions.
If you evaluate diagnostics for a living, we want to hear from you. Let's talk about the science, the evidence, and how we could work together.